SVB Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SVB Wealth's NVO Position: Q3 2025 in Review
SVB Wealth sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 4,560 shares — an estimated $315K sold.
SVB Wealth first reported a position in NVO in Q2 2020 and held it in 19 quarters. The position peaked at $2.75M in Q4 2023. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- SVB Wealth reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- SVB Wealth sold 4,560 Novo Nordisk shares in Q3 2025, an estimated $315K.
- SVB Wealth first reported a position in Novo Nordisk in Q2 2020 and held it in 19 quarters.
- SVB Wealth's Novo Nordisk position peaked at $2.75M in Q4 2023.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on SVB Wealth's 13F filing for Q3 2025, filed 6 Nov 2025.